Clinical Correlates of Similar Pathologies in Parkinsonian Syndromes

被引:15
|
作者
Song, Yun Ju Christine
Huang, Yue
Halliday, Glenda Margaret [1 ]
机构
[1] Neurosci Res Australia, Randwick, NSW 2031, Australia
基金
英国医学研究理事会;
关键词
atrophy; clinical features; multiple system atrophy; Parkinson's disease; pathological severity; progressive supranuclear palsy; PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE SYSTEM ATROPHY; SUPERIOR CEREBELLAR PEDUNCLE; DOPAMINE TRANSPORTER; DIAGNOSTIC-CRITERIA; DISEASE; MRI; INVOLVEMENT; DISORDERS; SUBTYPES;
D O I
10.1002/mds.23336
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There have been no previous studies assessing the severity of regional atrophy, cell loss and lesion densities between the overlapping conditions of Parkinson's disease (PD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) and relating these pathologies to different clinical features. Methods: Clinical indices and basal ganglia, brainstem, and cerebellar pathology from 43 longitudinally studied cases (PD = 8, PSP = 15, MSA = 12, controls = 8) were compared. A point-counting method was used to evaluate subregional volumes, and a-synuclein and phospho-tau immunohistochemistry was used to assess pathological inclusions and stage disease severity. Logistic regression analyses were used to identify pathological associations with clinical features. Results: All PD, PSP, and MSA cases had severe degeneration of the substantia nigra. Clinical features correlated with tissue loss and the severity of inclusion pathologies. Levodopa responsiveness and a lack of resting tremor was associated with preservation of pallidal volume, the presence of gait ataxia was associated with atrophy of the putamen, and the parkinsonian-plus phenotype with early falls and supranuclear vertical gaze abnormalities had more substantial midbrain atrophy and greater inclusion pathology in the caudate nucleus Discussion: This is the first study to compare the severity of regional pathologies across parkinsonian conditions. The data show that tissue loss and inclusion densities in certain regions correlate with clinical indices, with regional volume changes likely to be the best indicator of clinical progression of disease. (C) 2011 Movement Disorder Society
引用
收藏
页码:499 / 506
页数:8
相关论文
共 50 条
  • [41] Fracture Risk Assessment in Atypical Parkinsonian Syndromes
    Kobylecki, Christopher
    Glasse, Hannah
    Amin, Jigisha
    Gregson, Celia L.
    Lyell, Veronica
    Henderson, Emily J.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (03): : 385 - 389
  • [42] Morphometry MRI in the differential diagnosis of parkinsonian syndromes
    Gama, Romulo L.
    Tavora, Daniel F. G.
    Bomfim, Rodrigo C.
    Silva, Cruiff E.
    de Bruin, Veralice M.
    de Bruin, Pedro F.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2010, 68 (03) : 333 - 338
  • [43] Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach
    Tomaž Rus
    Petra Tomše
    Luka Jensterle
    Marko Grmek
    Zvezdan Pirtošek
    David Eidelberg
    Chris Tang
    Maja Trošt
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2901 - 2910
  • [44] Oculomotor changes as differential diagnosis in Parkinsonian syndromes
    Pinkhardt, E. H.
    Kassubek, J.
    NERVENHEILKUNDE, 2011, 30 (04) : 259 - 262
  • [45] Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes
    Kobylecki, Christopher
    Counsell, Serena J.
    Cabanel, Nicole
    Waechter, Tobias
    Turkheimer, Federico E.
    Eggert, Karla
    Oertel, Wolfgang
    Brooks, David J.
    Gerhard, Alexander
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (05) : 527 - 532
  • [46] Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes
    Gorges, Martin
    Maier, Melanie N.
    Rosskopf, Johannes
    Vintonyak, Olga
    Pinkhardt, Elmar H.
    Ludolph, Albert C.
    Mueller, Hans-Peter
    Kassubek, Jan
    JOURNAL OF NEUROLOGY, 2017, 264 (09) : 1919 - 1928
  • [47] Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
    Saeed, Usman
    Compagnone, Jordana
    Aviv, Richard I.
    Strafella, Antonio P.
    Black, Sandra E.
    Lang, Anthony E.
    Masellis, Mario
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [48] Parkinsonian syndromes and differential diagnosis
    Kashmere, J
    Camicioli, R
    Martin, W
    CURRENT OPINION IN NEUROLOGY, 2002, 15 (04) : 461 - 466
  • [49] Concomitant pathologies among a spectrum of parkinsonian disorders
    Dugger, Brittany N.
    Adler, Charles H.
    Shill, Holly A.
    Caviness, John
    Jacobson, Sandra
    Driver-Dunckley, Erika
    Beach, Thomas G.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (05) : 525 - 529
  • [50] Clinical Practices and Opinions toward Gastrostomy Use in Patients with Atypical Parkinsonian Syndromes: A National Survey in the UK
    Kobylecki, Christopher
    Goh, Yee Yen
    Mohammad, Rahema
    Beat, Alanna
    Michou, Emilia
    Pavey, Samantha
    Morris, Huw
    Houlden, Henry
    Chelban, Viorica
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (10): : 1266 - 1273